Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE STEMI ONE
2021-005499-20Phase 4Active
- Sponsor
- Research Cardiologen Rotterdam Zuid
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Research Cardiologen Rotterdam Zuid. Started May 2022; status: active.
02
Drugs
prasugrel
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2021-005499-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005499-20.